ErbB Receptors

Name: 온고지신 AI
Author: 머프키치

ErbB Receptors을(를) 다룬 문헌 21편. 초록 원문과 구조 요약은 무료 계정으로 열람할 수 있습니다.

Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis.체계적 고찰·메타분석 · Chinese journal of integrative medicine · 2026
Molecular and Cellular Basis of Oral Lichen Planus: Bridging Pathogenesis and Modern Clinical Paradigms.종설 · International journal of molecular sciences · 2026
Acupuncture-associated gastric mucosal repair and the EGF-EGFR-related signaling network: evidence, limitations, and prospects.종설 · Frontiers in immunology · 2026
Study on mechanism of Spatholobi Caulis in the treatment of the hand-foot skin reaction induced by targeted drug therapy based on network pharmacology and molecular docking: An observational study.관찰 연구 · Medicine · 2025
External Application of a Xiaozhen zhiyang Decoction for Facial Rash Related to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Chinese Patients: A Prospective Single-Arm Observational Study.관찰 연구 · Integrative cancer therapies · 2025
Effect of Huaiqihuang Granules Combined with Comprehensive Nursing on Children with Primary Nephrotic Syndrome.무작위 대조 시험 · Journal of healthcare engineering · 2022
Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.체계적 고찰·메타분석 · Medicine · 2022
Efficacy of Prophylactic Traditional Chinese Medicine on Skin Toxicity of Afatinib in EGFR Mutation-Positive Advanced Lung Adenocarcinoma: A Single-Center, Prospective, Double-Blinded, Randomized-Controlled Pilot Trial.무작위 대조 시험 · Integrative cancer therapies · 2022
A Single-Arm Phase II Study to Evaluate Efficacy and Safety of First-Line Treatment With DCVAC/LuCa, Standard of Care Chemotherapy and Shenqi Fuzheng Injection in Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer Patients.유형 미상 · Integrative cancer therapies · 2022
Chinese herbal formula shen-ling-bai-zhu-san to treat chronic gastritis: Clinical evidence and potential mechanisms.체계적 고찰·메타분석 · World journal of gastroenterology · 2022
Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs.체계적 고찰·메타분석 · Medicine · 2022
Long-term progression-free survival in a patient with advanced non-small-cell lung cancer treated with low-dose gefitinib and traditional herbal medicine: A case report.증례 보고 · Medicine · 2021
Investigation on the clinical efficacy and mechanism of compound kushen injection in treating esophageal cancer based on multi-dimensional network meta-analysis and in vitro experiment.체계적 고찰·메타분석 · Journal of ethnopharmacology · 2021
Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.체계적 고찰·메타분석 · Medicine · 2020
Chinese herbal medicine for epidermal growth factor receptor inhibitor-induced skin rash in patients with malignancy: An updated meta-analysis of 23 randomized controlled trials.체계적 고찰·메타분석 · Complementary therapies in medicine · 2019
Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.무작위 대조 시험 · Chinese journal of integrative medicine · 2018
Chinese Herbal Medicine for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.체계적 고찰·메타분석 · The American journal of Chinese medicine · 2018
[Cohort Study of EGFR-TKIs Combined with Traditional Chinese Medicine and Single EGFR-TKIs for Advanced NSCLC (Non(-)small Cell Lung Cancer)].유형 미상 · Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2018
[Meta-analysis on effectiveness and safety of traditional Chinese medicine combined with first-generation EGFR-TKI in treating advanced non-small cell lung cancer].체계적 고찰·메타분석 · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2017
Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.무작위 대조 시험 · Trials · 2015

다른 주제 보기 · 학술지별로 보기